Libre 3 Sensors: With Second Plant Online, Abbott Aims For Under-Penetrated ‘Intensive Insulin’ Segment

International sales could be a key driver as firm also looks to partnerships with insulin pump companies.

 
• By Shubham Singh
  
Despite previous supply challenges, Abbott said in its earnings call that it continues to report robust growth in the continuous glucose monitoring (CGM) market. (Shutterstock)

More from Business

More from Device Area